Antibody response dynamics to CoronaVac vaccine and booster immunization in adults and the elderly: A long-term, longitudinal prospective study-Reference-Cited by-同舟云学术

Antibody response dynamics to CoronaVac vaccine and booster immunization in adults and the elderly: A long-term, longitudinal prospective study

Published:2023-06 Issue: Volume:7 Page:222-229
ISSN:2772-7076
Container-title:IJID Regions
language:en
Short-container-title:IJID Regions

Author:

Volpe Gustavo Jardim^ORCID,Vessoni Sandra Coccuzzo Sampaio,Soares Lais Braga,Leite dos Santos Almeida Maria Aparecida Alves,Braga Patrícia Emília,de Moraes Glenda Renata,Ferreira Natasha Nicos^ORCID,Garibaldi Pedro Manoel Marques^ORCID,Kashima Simone,Fonseca Benedito Antônio Lopes,Calado Rodrigo Tocantins,García Hugo Alberto Brango,de França João Italo Dias,de Lima Marcos Alves^ORCID,Pacheco Pedro Henrique de Mesquita,Borges Marcos Carvalho^ORCID,Covas Dimas Tadeu^ORCID

Funder

Instituto Butantan

Fundação de Amparo à Pesquisa do Estado de São Paulo

Fundação Butantan

Publisher

Elsevier BV

Reference33 articles.

1. An interactive web-based dashboard to track COVID-19 in real time;Dong;Lancet Infect Dis,2020

2. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet,2022

3. Vacinômetro COVID-19,2021

4. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial;Wu;Lancet Infect Dis,2021

5. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial;Zhang;Lancet Infect Dis,2021